(Q43840719)

English

A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study

scientific article published in November 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Mullen J

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Jibson MD

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sweitzer D

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 November 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1839-1854

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quetiapine fumarate (Seroquel): a new atypical antipsychotic

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atypical antipsychotics and weight gain--a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The long-term effect of quetiapine (Seroquel TM ) monotherapy on weight in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

An open comparison of clozapine and risperidone in treatment-resistant schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophrenic patients: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy of risperidone and clozapine in the treatment of patients with refractory schizophrenia or schizoaffective disorder: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Why do schizophrenic patients refuse to take their drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2989080-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(00)89080-3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43840719&oldid=2103792674"